ONE-WAYOngoing theme · still written in the latest filings
Phase 3 development in Europe and the United States of SB623 for chronic-phase traumatic brain injury
An individual drug development theme involving Phase 3 clinical trials in Europe and the United States for SB623 for chronic-phase traumatic brain injury, with development proceeding based on consultations with the FDA and EMA.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.